A Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of VG2025 Intravenous Injection in Subjects With Advanced Solid Tumors
Clinical trial NCT07682870 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07682870
- Sponsor
- Virogin Biotech Ltd.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-09-04
- Primary completion
- 2028-12-02
- Enrollment
- 42
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.